Sequencing and array-based solutions for genetic research, clinical and applied markets
Discussions related to genomics, sequencing and the applications for sequencing including in rare disease and related reimbursement; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Ongoing monitoring of CDC surveillance funding; Chips and Science Act (PL 117-167); H.R. 791/S. 236, Tracking COVID-19 Variants Act; H.R. 5376, Inflation Reduction Act of 2022; H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act; S. 3819, Advanced Research Project Authority for Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; H.R. 7007, COVID Supplemental Appropriations Act, 2022; S. 3799, PREVENT Pandemics Act; Issues related to the FY 2023 President's Budget; S.3534/H.R.7152, Tracking Pathogens Act; Issues related to reauthorization of FDA user fee bills (H.R. 7667, Food and Drug Amendments of 2022; S. 4348 Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including H.R. 4281/S. 2209, VALID Act
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
TRACY SPICER JORDAN A LACROSSE